FTC V. Actavis: Reconciling Conflicts In Rule Of Reason
The U.S. Supreme Court's June 17 decision in Federal Trade Commission v. Actavis has already spawned a cascade of commentary. Its core holding has big implications for the pharmaceutical industry: The...To view the full article, register now.
Already a subscriber? Click here to view full article